Company Filing History:
Years Active: 2015-2018
Title: Christina McLaughlin: Innovator in Mixed Metal Complexes
Introduction
Christina McLaughlin is a prominent inventor based in Albany, NY (US). She has made significant contributions to the field of chemistry, particularly in the development of new chemical entities and mixed metal complexes. With a total of 3 patents to her name, McLaughlin is recognized for her innovative approaches to treating conditions caused by oxidative stress.
Latest Patents
Among her latest patents is Calmangafodipir, a new chemical entity that showcases her expertise in creating mixed metal complexes. This invention outlines methods for treating pathological conditions caused by oxidative stress in patients. The treatment involves administering a mixed metal complex of a compound of Formula I, or a salt thereof, in an effective amount to reduce oxidative stress. The pharmaceutical compositions are designed by suspending or dissolving the mixed metal complex in a liquid medium, potentially combined with one or more physiologically acceptable excipients. The mixed metals utilized in her research include calcium and manganese, with a specific molar ratio that enhances their effectiveness.
Career Highlights
Christina McLaughlin has established herself as a key figure in her field through her innovative research and development efforts. Her work at Pledpharma Ab has allowed her to focus on creating solutions that address significant health challenges. Her dedication to advancing pharmaceutical science is evident in her patent portfolio and ongoing research initiatives.
Collaborations
Throughout her career, McLaughlin has collaborated with notable colleagues, including Jan-Olof G Karlsson and Karl Reineke. These partnerships have contributed to her success and the advancement of her research projects.
Conclusion
Christina McLaughlin is a trailblazer in the field of mixed metal complexes and pharmaceutical innovations. Her contributions to the treatment of oxidative stress-related conditions highlight her commitment to improving patient outcomes through scientific advancements.